Keyphrases
Nanoparticles
100%
P-glycoprotein (P-gp)
100%
Paclitaxel
100%
Drug Efflux
100%
Tumor Cells
25%
Multidrug Resistance
25%
Resistant Cells
25%
P-glycoprotein Substrate
25%
Verapamil
25%
PLGA Nanoparticles
25%
Multidrug-resistant
12%
Overexpression
12%
Cytotoxicity
12%
Cancer Cells
12%
Sustained Release
12%
Therapeutic Efficacy
12%
Drug Sensitivity
12%
Dose Effect
12%
Encapsulated Drugs
12%
Emulsion Solvent Evaporation
12%
Poly(d,l-lactide-co-glycolide)
12%
Hydrodynamic Radius
12%
MCF-7
12%
Efflux
12%
P-glycoprotein Inhibitor
12%
Nanotoxicity
12%
In Vitro Cell-culture Study
12%
Multidrug Resistance in Cancer
12%
Paclitaxel Nanoparticles
12%
Pharmacology, Toxicology and Pharmaceutical Science
P-Glycoprotein
100%
Nanoparticle
100%
Paclitaxel
100%
Effusion
100%
Multiple Drug Resistance
30%
Cytotoxicity
20%
Verapamil
20%
Neoplasm
20%
Sustained Release
10%
Cell Culture
10%
Malignant Neoplasm
10%
Polyglactin
10%
Glycoprotein P Inhibitor
10%
Combination Therapy
10%
Neuroscience
Paclitaxel
100%
ABC Transporter Subfamily B
100%
Cytotoxicity
18%
PLGA
18%
Verapamil
18%
In Vitro
9%
Cell Culture
9%